ISRCTN03150596CompletedNot Applicable
Randomised placebo controlled trial of nicotine nasal spray for smoking cessation in primary care
McNeil AB (Sweden) - formally Pharmacia and Upjohn0 sites1,200 target enrollmentStarted: April 15, 2010Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 1,200
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. Smokers: smoking for at least 3 years
- •2. Aged 20 - 60 years, either sex
- •3. Smokes 15 or more cigarettes a day
- •4. Motivated to stop
Exclusion Criteria
- •1. Myocardial infarction within 3 years
- •2. Chronic nasal disorder
- •3. Pregnancy, intending pregnancy
- •4. Breast feeding
- •5. Current psychiatric care
- •6. Current use of psychotropic drugs
Investigators
Similar Trials
Completed
Phase 3
RELIQ Study: Reduced levels of nicotine in cigarettes to increase quittingACTRN12608000410358Heath Research Council NZ1,410
Withdrawn
Not Applicable
The Vaccination Infant Supplementation (VISS) Study - assessing the effect of vitamin D and probiotic supplementation around vaccination on infant's temperature and sleep pattern.ACTRN12618001992291AProf Dr Karin Ried50
Not yet recruiting
Phase 3
A clinical trial to examine the immunomodulatory effect of Triphala in Upper Respiratory Tract Illness in adultsCTRI/2022/08/045079CSIRCIMAP
Recruiting
Not Applicable
Development and implementation of a smoking cessation support program for middle-aged and older men with chronic obstructive pulmonary diseasechronic obstructive pulmonary diseaseJPRN-UMIN000048212Sophia University40
Active, not recruiting
Not Applicable
Smoking cessatioEUCTR2012-002731-28-PLBioprojet250